Austar Lifesciences Ltd. (HK:6118) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Austar Lifesciences Limited has scheduled a Board meeting on August 27, 2024, to review the Group’s unaudited financial results for the first half of the year and to consider the possibility of declaring an interim dividend. The meeting will be critical for shareholders looking to understand the company’s recent financial performance and dividend prospects.
For further insights into HK:6118 stock, check out TipRanks’ Stock Analysis page.